About Cosmos Health Inc.
Ticker
info
COSM
Trading on
info
NASDAQ
ISIN
info
US2214133058
Industry
info
Medical Distribution
Sector
info
Healthcare
CEO
info
Grigorios Siokas
Headquarters
info
141 West Jackson Boulevard, Chicago, IL, United States, 60604
Employees
info
149
Website
info
cosmoshealthinc.com
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Metrics
BasicAdvanced
Market cap
info
$16.6M
P/E ratio
info
-
EPS
info
-$0.77
Dividend Yield
info
0.00%
Beta
info
4.47
Forward P/E ratio
info
52.63
EBIDTA
info
$-12.6M
Ex dividend date
info
-
Price & volume
Market cap
info
$16.6M
Average daily volume
info
0.6M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
52.63
PEG ratio
info
0
Trailing P/E
info
0
Price to sales
info
0.23
Price to book
info
0.58
Earnings
EPS
info
-$0.77
EPS estimate (current quarter)
info
-$0.09
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-12.6M
Revenues (TTM)
info
$59.8M
Revenues per share (TTM)
info
$2.20
Technicals
Beta
info
4.47
52-week High
info
$1.32
52-week Low
info
$0.28
50-day moving average
info
$0.58
200-day moving average
info
$0.64
Short ratio
info
0.23
Short %
info
0.48%
Management effectiveness
ROE (TTM)
info
-63.82%
ROA (TTM)
info
-13.03%
Profit margin
info
-31.01%
Gross profit margin
info
$6.8M
Operating margin
info
-10.63%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
37.90%
Share stats
Outstanding Shares
info
37.3M
Float
info
25.4M
Insiders %
info
27.10%
Institutions %
info
8.02%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 1 analysts.

Average price target

info
$4.50
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.45
-$0.11
-309.09%
Q3 • 24Missed
-$0.41
-$0.08
-412.50%
Q1 • 25Missed
-$0.10
$0.01
-1,100.00%
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$14.7M
$-2.8M
-19.18%
Q2 • 25
$17.1M
$-5.4M
-31.28%
Q3 • 25
16.04%
89.28%
63.12%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$61.8M
$35.6M
57.58%
Q2 • 25
$69.5M
$46.4M
66.71%
Q3 • 25
12.38%
30.20%
15.86%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-1.2M
$0.1M
$1.6M
$-1.3M
Q2 • 25
$-4M
$-1M
$8.7M
$-4M
Q3 • 25
228.22%
-1,506.34%
442.79%
199.88%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Cosmos Health Inc. share?
Collapse

Cosmos Health Inc. shares are currently traded for undefined per share.

How many shares does Cosmos Health Inc. have?
Collapse

Cosmos Health Inc. currently has 37.3M shares.

Does Cosmos Health Inc. pay dividends?
Collapse

No, Cosmos Health Inc. doesn't pay dividends.

What is Cosmos Health Inc. 52 week high?
Collapse

Cosmos Health Inc. 52 week high is $1.32.

What is Cosmos Health Inc. 52 week low?
Collapse

Cosmos Health Inc. 52 week low is $0.28.

What is the 200-day moving average of Cosmos Health Inc.?
Collapse

Cosmos Health Inc. 200-day moving average is $0.64.

Who is Cosmos Health Inc. CEO?
Collapse

The CEO of Cosmos Health Inc. is Grigorios Siokas.

How many employees Cosmos Health Inc. has?
Collapse

Cosmos Health Inc. has 149 employees.

What is the market cap of Cosmos Health Inc.?
Collapse

The market cap of Cosmos Health Inc. is $16.6M.

What is the P/E of Cosmos Health Inc.?
Collapse

The current P/E of Cosmos Health Inc. is null.

What is the EPS of Cosmos Health Inc.?
Collapse

The EPS of Cosmos Health Inc. is -$0.77.

What is the PEG Ratio of Cosmos Health Inc.?
Collapse

The PEG Ratio of Cosmos Health Inc. is 0.

What do analysts say about Cosmos Health Inc.?
Collapse

According to the analysts Cosmos Health Inc. is considered a buy.